This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wong, W.-M. Articles by Wright, N. A. Search for Related Content PubMed PubMed Citation Articles by Wong, W.-M. Articles by Wright, N. A. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

Epidermal Growth Factor, Epidermal Growth Factor Receptors, Intestinal Growth, and Adaptation

Department of Histopathology, Imperial College of Science, Technology and Medicine, Hammersmith Campus, London, England, Histopathology Unit, Imperial Cancer Research Fund, London, England, Gastroenterology and Hepatology Division, University Department of Medicine, Queen Mary Hospital, University of Hong Kong

Nicholas A. Wright, MD, PhD, DSc, FRCPath

Department of Histopathology, Imperial College of Science, Technology and Medicine, Hammersmith Campus, London, England, Histopathology Unit, Imperial Cancer Research Fund, London, England

Epidermal growth factor (EGF) is an important constituent of several gastrointestinal secretions. Many studies in both animals and humans have shown EGF to have multiple effects upon gut epithelial cells. These include cytoprotection, stimulatory effects on cell proliferation and migration, induction of gene expression such as mucosal enzymes and trefoil proteins, and inhibitory effects on gastric acid secretion. The main conundrum associated with EGF action is the disparity between experimental studies on its luminal and systemic actions. Opinion is sharply divided as to whether or not EGF has any action when given luminally and on the site of the EGF receptors on gut epithelial cells. Most studies agree that the EGF receptors are located on the basolateral surface, in which case EGF should only be active if surface ulceration has occurred—unless there is translocation across the epithelium. There are several clinical situations in which EGF might be useful in cytoprotection and in stimulating repair and regeneration in the gut. These include necrotizing enterocolitis and mucositis, and it is to be hoped that the solid basis of experimental studies on EGF might stimulate work on this topic. (Journal of Parenteral and Enteral Nutrition 23:S83-S88, 1999)

Journal of Parenteral and Enteral Nutrition, Vol. 23, No. 5 Suppl, S83-S88 (1999)
DOI: 10.1177/014860719902300521


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?